Development and Application of the COPD Medication Assistant

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
INTERVENTION: Control group:Conventional health education;Intervention group:AI interactive scenario guidance and exclusive visual animation intervention; CONDITION: Chronic Obstructive Pulmonary Disease PRIMARY OUTCOME: AI Usage Selectivity Score in Low/High‐Risk Scenarios; SECONDARY OUTCOME: Chronic Obstructive Pulmonary Disease Knowledge Questionnaire;Willingness to use mobile AI assistants in low‐risk scenarios; INCLUSION CRITERIA: 1. Age is 18 years or above; 2. Diagnosed by a doctor and clinically confirmed as chronic obstructive pulmonary disease; 3. Voluntarily participate in this clinical study and sign a written informed consent form.
Epistemonikos ID: a0a9d529187377ca41a6dfb64b0cc92afecdd48a
First added on: Sep 12, 2026